Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
42.63
-0.16 (-0.37%)
At close: Sep 29, 2025

Novoprotein Scientific Company Description

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, and molecular enzymes and reagents; and gene and cell therapy, molecular research and diagnosis, and SRAS-CoV-2 and SARS-CoV-2 related products, as well as related technical services.

The company also provides protein expression and purification, antibody, industrial strain and process development, stable cell line, VLP protein, protein crystallization, protein modification and labeling, MHC I-peptide complex protein preparation, antibody development, mRNA synthesis custom, and vaccine development services.

It offers its products and services in the fields of biopharmaceuticals, mRNA vaccines and drugs, in vitro diagnostics, biological drugs, basic research of life sciences, and other areas.

The company was founded in 2009 and is headquartered in Suzhou, China.

Novoprotein Scientific Inc.
CountryChina
Founded2009
IndustryBiotechnology
SectorHealthcare
Employees566
CEOHuaxing Zhu

Contact Details

Address:
No.228, Yunchuang Road
Suzhou, 215299
China
Phone86 512 6391 9116
Websitenovoprotein.com.cn

Stock Details

Ticker Symbol688137
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
SIC Code2836

Key Executives

NamePosition
Dr. Huaxing ZhuFounder, Chairman and GM
Dongye ZhangAccounting Supervisor and Chief Financial Officer
Yingming WangDeputy GM and Director
Yujian ZhaoDeputy GM and Director
Duqiang WangDeputy GM, Secretary and Director